Quoin Pharmaceuticals Signs At-the-Market Share Sales Agreement With Leerink Partners

PUBT · 1d ago
Quoin Pharmaceuticals Signs At-the-Market Share Sales Agreement With Leerink Partners
  • Quoin Pharmaceuticals entered an at-the-market sales agreement with Leerink Partners on November 4, 2026, to sell American Depositary Shares through the agent.
  • Each ADS represents 35 ordinary shares; Leerink Partners will receive 3% of gross proceeds from sales through it.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quoin Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-122790), on November 04, 2026, and is solely responsible for the information contained therein.